Amneal Pharmaceuticals, Inc. (AMRX)
14.87
+0.24
(+1.64%)
USD |
NASDAQ |
Feb 13, 14:16
Amneal Pharmaceuticals Cash from Investing (Quarterly) : -22.46M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 14.64M |
| Pfizer Inc. | -- |
| Apellis Pharmaceuticals, Inc. | -0.148M |
| Nektar Therapeutics | -94.87M |
| Innoviva, Inc. | 18.41M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 118.45M |
| Cash from Financing (Quarterly) | 59.44M |
| Free Cash Flow | 236.43M |
| Free Cash Flow Per Share (Quarterly) | 0.2956 |
| Free Cash Flow to Equity (Quarterly) | -7.845M |
| Free Cash Flow to Firm (Quarterly) | -122.08M |
| Free Cash Flow Yield | 4.97% |